Skip to content
Menu
Menu
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact
Menu
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact
Regulatory News
Results of General Meeting
13 January 2022
13 December 2021
Conditional Placing to Raise £3 Million (Before Expenses)
12 January 2022
22 November 2021
Proposed Acquisition of Lyramid Pty Limited
12 January 2022
18 November 2021
Update on Acquisition of Lyramid Limited
12 January 2022
12 November 2021
INTERIM RESULTS TO 30 JUNE 2021
12 January 2022
29 October 2021
Board Changes
12 January 2022
20 October 2021
Reverse Takeover Transaction and Suspension of Trading
12 January 2022
29 September 2021
Holding(s) in Company
12 January 2022
26 August 2021
Holding(s) in Company
12 January 2022
24 August 2021
Holding(s) in Company
12 January 2022
18 August 2021
Older posts
Page
1
Page
2
Next
→
STAY INFORMED VIA OUR EMAIL ALERTS
Register
Next Page »
Close
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact